https://www.thefocalpoints.com/p/breaking-first-in-man-oral-proteolytic?

BREAKING–First-in-Man Oral Proteolytic and Thrombolytic Dissolution of Intra-Arterial COVID-19 Vaccine Thrombi

Complex Blend of Oral Enzymes and Natural Ingredients Clears Brain Fog and Removes Impending Stroke Risk in Heavily Vaccinated Patient

Article Excerpt:

In this breaking interview, Dr. Takuji Shirasawa from the Ochanomizu Health and Longevity Clinic  describes a 60-year old Japanese man who took 4 Pfizer COVID-19 vaccines and presented with a loss of mental clarity otherwise known as “brain fog.” Shirasawa used MR angiography to demonstrate sessile bilateral arterial thrombi in the carotid bulbs. His hypothesis was that mini-blood clots may be responsible for the neurological and cognitive symptoms.

Shirasawa performed a N-of-1 trial giving the patient a complex blend of oral proteolytic and thrombolytic enzymes featuring nattokinase, bromelain, serrapeptase, and papain adding over a dozen natural ingredients given in proprietary blends from Texas based Phytomedic Labs. The patient was also administered aspirin 100 mg per day.  (See link for article & video)

_______________

For more: